In Vivo Toxicology Market is Anticipated to Expand upto $7.31 Billion in 2029

Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.

What Is the Forecasted Market Growth Rate of the In Vivo Toxicology Industry?
There has been substantial growth in the in-vivo toxicology market in the previous years. The market size, which is predicted to increase from $5.24 billion in 2024 to $5.61 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 7.1%. This surge through the historic period can be credited to a growing demand for GLP-compliant investigations, expansion of reach directives, an increase in biologics and biosimilars that need safety assessments, rise in investment towards the development of oncology drugs, and the widening of gene and cell therapy pipelines.

How Will the In Vivo Toxicology Market Size Evolve From 2025 to 2029?
The market size for in-vivo toxicology is projected to witness considerable expansion in the forthcoming years, reaching $7.31 billion in 2029, with a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is due to factors such as the increase in drug development endeavours globally, higher demand for customized medicine, a growing number of clinical trials, more outsourcing of toxicology testing from pharmaceutical companies, and escalating concerns over consumer safety in the domains of food and personal care items. Future trends projected during this period encompass advancements in animal models, the incorporation of imaging technologies into in vivo studies, the advent of automated systems for data collection, the use of AI and ML for toxicology data analysis, and strides in telemetry and biomarker detection in animals.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

What Are the Main Growth Drivers in the In Vivo Toxicology Market Today?
The escalating volume of drug innovations is predicted to spur the expansion of the in vivo toxicology market. Identifying and crafting potential treatment and preventative compounds for various ailments is a part of drug discovery. Biotechnology advancements have accelerated this procedure by improving disease comprehension and catalyzing the production of more directed treatments. In vivo toxicology is a critical component of drug discovery, as it allows for the testing of safety, tolerance, and potential side effects of experimental compounds in full organisms. It also helps in identifying toxic doses and guides the formation and dosing strategies prior to clinical experimentation. For example, as indicated in a May 2025 article by the Canadian Government, a constitutional body based in Canada, the global count of medicines undergoing clinical trials was 10,134 in March 2025, reflecting a 20% increase from September 2021. As such, the growing number of drug innovations is propelling the expansion of the in vivo toxicology market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

Which In Vivo Toxicology Market Segment Is Expected to Lead Through 2029?
The in vivo toxicology market covered in this report is segmented -

1) By Product: Consumables, Instruments
2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing
3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals
4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications
5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:
1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents
2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

Which Market Trends Are Expected to Dominate In Vivo Toxicology Industry Growth?
Leading businesses involved in the in vivo toxicology scene are prioritizing the creation of cutting-edge solutions like secure, real-time, cloud-based data platforms to facilitate streamlined study management and expedite decision-making processes. These platforms offer researchers and customers secure and remote access to various resources, including toxicology study data, planning tools, milestones, and other documents, thereby promoting enhanced cooperation and transparency. For example, Charles River Laboratories International Inc., a US-based contract research organization, unveiled Apollo, a secure cloud-based platform offering real-time toxicology study data access, in March 2023. Apollo is a secure cloud-based platform specifically built to bolster in vivo general toxicology studies through data visualization, planning, and milestone tracking tools. The platform facilitates faster and better-informed decision-making by delivering real-time access to essential study data. Additionally, it provides support in smoothing out project planning and budget estimation throughout the drug development phase. Through the digitization of toxicology workflows, Apollo advances accuracy, productivity, and collaboration in in vivo research.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Which Companies Hold the Largest Market Share in the In Vivo Toxicology Sector?
Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.

Where Is the In Vivo Toxicology Market Experiencing the Highest Growth?
North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.